The effectiveness of EMDR vs EMDR 2.0 vs the Flash technique in the treatment of patients with PTSD: A Randomized Controlled Trial

The effectiveness of EMDR vs EMDR 2.0 vs the Flash technique in the treatment of patients with PTSD: A Randomized Controlled Trial - Effectiveness of EMDR vs. EMDR 2.0 vs. the Flash technique

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON54264

Enrollment

130

Registered

2022-07-14

Start date

2022-09-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumagerelateerde stoornissen PTSD Posttraumatic Stress Disorder Trauma

Interventions

There are three treatment conditions: EMDR, EMDR 2.0 and the Flash technique. Patients are divided at random to one of the three treatment conditions. The treatments consist of six weekly sessions o

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Estimated IQ > 80 PTSD diagnosis according to the DSM-5 18 years or older Sufficient understanding of the Dutch language

Exclusion criteria

Exclusion criteria: Acute suicidality PTSD diagnosis not the primary diagnosis Changes in medication during, or 6 weeks prior to participation in the research Use of strongly sedating medication

Design outcomes

Primary

Measure	Time frame
The primary dependent variables for measuring the effectiveness of the treatment are the presence of the diagnosis PTSD (CAPS-5) and complex PTSD (ITQ) and the severity of PTSD symptoms (PCL-5, CAPS-5, ITQ). The CAPS-5 and ITQ are administered before treatment and four and twelve weeks after termination of treatment.	—

Secondary

Measure	Time frame
De secondary dependent variables for measuring the effectiveness of treatment are depressive, dissociative and general psychiatric symptoms (BDI, DES and BSI respectively) and experiential avoidance (AAQ-II). The dependent variables for measuring treatment efficiency are amount of treated targets per session and duration of each session. The dependent variables for measuring treatment acceptability are four open questions about treatment acceptability with answer options rated on a 7-point scale. Safety of the intervention will be measured with the amount of serious aversive events (SAEs). The PCL-5, BDI, BSI and AAQ-II will be adminstered weekly during the treatment period and biweekly until 12 weeks after termination of treatment. The treatment acceptability questionnaire will be adminstered after the first and final treatment session.	—

Measure

Time frame

De secondary dependent variables for measuring the effectiveness of treatment are depressive, dissociative and general psychiatric symptoms (BDI, DES and BSI respectively) and experiential avoidance (AAQ-II). The dependent variables for measuring treatment efficiency are amount of treated targets per session and duration of each session. The dependent variables for measuring treatment acceptability are four open questions about treatment acceptability with answer options rated on a 7-point scale. Safety of the intervention will be measured with the amount of serious aversive events (SAEs). The PCL-5, BDI, BSI and AAQ-II will be adminstered weekly during the treatment period and biweekly until 12 weeks after termination of treatment. The treatment acceptability questionnaire will be adminstered after the first and final treatment session.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)